-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Cuts Price Target on Haemonetics to $84 From $90, Reiterates Equalweight Rating

Morgan Stanley Cuts Price Target on Haemonetics to $84 From $90, Reiterates Equalweight Rating

MT Newswires · 01/06/2023 05:50